Literature DB >> 10361711

The Mycobacterium marinum G13 promoter is a strong sigma 70-like promoter that is expressed in Escherichia coli and mycobacteria species.

L P Barker1, S F Porcella, R G Wyatt, P L Small.   

Abstract

A Mycobacterium marinum promoter, designated G13, was isolated from a promoter-trap library as a constitutive producer of the mutant green fluorescent protein. Sequence analysis, primer extension analysis, and computer promoter prediction analysis indicate that the G13 promoter is very similar to Escherichia coli consensus sigma 70 promoters. Expression of the green fluorescent protein from the G13 promoter in M. marinum is, however, up to 40 times higher than that seen from the mycobacterial hsp60 promoter during exponential growth. Further, expression from this promoter does not appear to affect the growth of the organism in culture media or in macrophages. The strong expression of the G13 promoter allows it to be developed as a useful molecular tool for high level expression of markers in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361711     DOI: 10.1111/j.1574-6968.1999.tb13604.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.

Authors:  Paras Jain; Travis E Hartman; Nell Eisenberg; Max R O'Donnell; Jordan Kriakov; Karnishree Govender; Mantha Makume; David S Thaler; Graham F Hatfull; A Willem Sturm; Michelle H Larsen; Preshnie Moodley; William R Jacobs
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

2.  Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds.

Authors:  Vandana Singh; Rajesh Kumar Biswas; Bhupendra N Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

3.  Sporulation in mycobacteria.

Authors:  Jaydip Ghosh; Pontus Larsson; Bhupender Singh; B M Fredrik Pettersson; Nurul M Islam; Sailendra Nath Sarkar; Santanu Dasgupta; Leif A Kirsebom
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

4.  Mycobacterium marinum produces long-term chronic infections in medaka: a new animal model for studying human tuberculosis.

Authors:  Gregory W Broussard; Don G Ennis
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2006-08-12       Impact factor: 3.228

5.  Monitoring Tuberculosis Drug Activity in Live Animals by Near-Infrared Fluorescence Imaging.

Authors:  Raphael Sommer; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

6.  Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.

Authors:  Tianyu Zhang; William R Bishai; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

7.  Mycobacterium avium uses apoptotic macrophages as tools for spreading.

Authors:  Julie Early; Kay Fischer; Luiz E Bermudez
Journal:  Microb Pathog       Date:  2010-12-15       Impact factor: 3.738

8.  Molecular characterization of the eis promoter of Mycobacterium tuberculosis.

Authors:  Esteban A Roberts; Amanda Clark; Sarah McBeth; Richard L Friedman
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

9.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes).

Authors:  Gregory W Broussard; Michelle B Norris; Adam R Schwindt; John W Fournie; Richard N Winn; Michael L Kent; Don G Ennis
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-09-24       Impact factor: 3.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.